327 related articles for article (PubMed ID: 16366142)
1. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection.
Cojocaru M; Cojocaru IM; Iacob SA
Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142
[TBL] [Abstract][Full Text] [Related]
2. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection.
Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E
J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797
[TBL] [Abstract][Full Text] [Related]
3. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
4. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
Ordeig J; Guardia J
J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of anti-neutrophil cytoplasmic antibodies in patients with chronic hepatitis C infection associated mixed cryoglobulinemia.
Cojocaru M; Cojocaru IM; Iacob SA
Rom J Intern Med; 2006; 44(4):427-31. PubMed ID: 18386619
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study.
Boki KA; Kurki P; Holthofer H; Tzioufas AG; Drosos AA; Moutsopoulos HM
J Rheumatol; 1995 Nov; 22(11):2046-8. PubMed ID: 8596142
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis?
Salvador G; Gomez A; Vinas O; Ercilla G; Canete JD; Munoz-Gomez J; Sanmarti R
Rheumatology (Oxford); 2003 Aug; 42(8):972-5. PubMed ID: 12730510
[TBL] [Abstract][Full Text] [Related]
10. Arthritis in patients with chronic hepatitis C virus infection.
Rivera J; García-Monforte A; Pineda A; Millán Núñez-Cortés J
J Rheumatol; 1999 Feb; 26(2):420-4. PubMed ID: 9972979
[TBL] [Abstract][Full Text] [Related]
11. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
[TBL] [Abstract][Full Text] [Related]
12. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
13. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid factor and antikeratin antibody are independent from presence of DR4 or DR1 in rheumatoid arthritis.
Cantagrel A; Constantin A; Vincent C; Abbal M; Laroche M; Ohayon E; Serre G; Mazières B
Rev Rhum Engl Ed; 1999 Jan; 66(1):20-3. PubMed ID: 10036694
[TBL] [Abstract][Full Text] [Related]
15. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
16. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
18. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
[TBL] [Abstract][Full Text] [Related]
19. Significance of antikeratin antibodies in rheumatoid arthritis.
Hajiroussou VJ; Skingle J; Gillett AP; Webley M
J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092
[TBL] [Abstract][Full Text] [Related]
20. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
